IB Acquisition Corp. is asking shareholders to elect four directors, ratify MaloneBailey LLP as auditor for the fiscal year ending September 30, 2027, and authorize adjournment if votes are insufficient for the first two proposals. Its virtual annual meeting is scheduled for December 16, 2026. Holders of record on October 28, 2026 may vote; 4,890,843 common shares were outstanding on that date.
The ownership table lists sponsor I-B Good Works 4, LLC as beneficial owner of 2,837,576 shares (58.0%) and James Michael McCrory as beneficial owner of 1,016,514 shares (20.8%). IBAC says it has no business operations and, since its IPO, has focused on identifying and evaluating acquisition candidates. It discloses an administrative-services agreement paying CFO Christy Albeck $5,000 monthly; $60,000 in fees was incurred for the fiscal year ended September 30, 2025.
IB Acquisition Corp. scheduled its 2026 annual meeting for December 16, 2026, at 10:00 a.m. Eastern Time, to be held virtually by live webcast. The record date for stockholders entitled to notice of and to vote at the meeting is the close of business on October 28, 2026.
Stockholder proposals for inclusion in the proxy statement must be received by close of business October 26, 2026. Nasdaq notified the company on October 5, 2026, that it was not in compliance with Listing Rule 5620(a) because it had not held an annual meeting within 12 months of its fiscal year-end. IB Acquisition believes the December meeting will enable it to regain compliance; it will be the company’s first annual meeting since its initial public offering.
IB Acquisition Corp. received a Nasdaq determination letter on October 5, 2026, stating that it is not compliant with the Annual Meeting Requirement because it did not hold an annual meeting of shareholders within 12 months of the end of its fiscal year. The company has 45 calendar days to submit a plan to regain compliance; if Nasdaq accepts the plan, Nasdaq may grant an exception of up to 180 calendar days from fiscal year-end, or until March 29, 2027, to regain compliance. The company intends to submit a plan that includes a proxy statement preparation and proxy solicitation timeline leading to an annual meeting. The notice has no immediate effect on listing or trading, and the common stock will continue trading as IBAC during the compliance period.
IB Acquisition Corp. amended its pending business-combination arrangements with GNQ Insilico and disclosed a convertible-note financing and equity purchase facility. Under the Equity Purchase Facility Agreement, IBAC may, but is not obligated to, sell up to $50.0 million in aggregate gross purchase price of newly issued Class A common shares; the commitment period begins after the resale registration statement is declared effective and continues for up to 36 months. At the PIPE’s initial closing, the Buyer will purchase notes with an aggregate original principal amount of $16,470,588, with potential additional closings up to an aggregate principal amount of $90,000,000; the initial closing is conditioned on satisfaction or waiver of all business-combination conditions, including redomestication.
The PIPE Notes convert at an initial $10.00 per-share price, bear 12% annual interest (18% during a continuing event of default), and are secured by a first-priority interest in substantially all personal property. IBAC will issue a $675,000 convertible Commitment Note at business-combination closing for the facility. The amendment removes the Minimum Cash closing condition, requires outstanding Bridge Financing obligations to be exchanged for senior secured convertible notes at closing, and provides for issuance of 350,000 shares to the Buyer.
IB Acquisition Corp. (IBAC) announced multiple financing arrangements and amendments related to its pending business combination with GNQ Insilico Inc. The company entered into an Equity Purchase Facility giving it the right to sell up to $50.0 million of Class A common stock to an institutional investor over a commitment period of up to 36 months, subject to a 4.99%–9.99% beneficial ownership cap and a 19.99% exchange cap unless stockholders approve more. As consideration, IB Acquisition will issue a $675,000 convertible commitment note.
The company, GNQ and a buyer also signed a Securities Purchase Agreement for senior secured convertible notes, with an initial closing of $16,470,588 in principal and potential additional closings up to $90,000,000. These PIPE Notes bear 12% interest (increasing to 18% upon default), mature in 12 months, are convertible at an initial price of $10.00 per share, and are secured by a first-priority lien on substantially all personal property of IB Acquisition and its subsidiaries. An amendment to the Business Combination Agreement removes the minimum cash closing condition, requires outstanding bridge financing to roll into notes under this structure, and provides for the issuance of 350,000 Class A shares to the buyer, while releasing 610,500 sponsor private placement units from a six‑month lock‑up.
IB Acquisition Corp. (IBAC) is asking stockholders to approve several changes that would give the company more time to complete its initial business combination and avoid an automatic wind‑up. The main proposal extends the business‑combination deadline by six months, from September 28, 2026 to March 28, 2027, by amending the charter; this requires approval by holders of at least 65% of outstanding common shares, including Founder Shares.
A second proposal amends the Investment Management Trust Agreement so the Trust Account terms match the new deadline, and a third allows adjournment of the meeting if more time is needed to solicit votes. Public stockholders may redeem their shares in connection with the extension for cash equal to their pro rata share of the Trust Account, which held approximately $8.3 million as of the record date, implying an expected redemption price of about $10.93 per share. If the extension is not approved and no business combination closes by September 28, 2026, IB Acquisition must redeem 100% of public shares from the Trust Account and then dissolve, leaving only liquidation value and no future upside from any potential transaction.
IB Acquisition Corp., a SPAC, reported a net loss of $567,166 for the quarter and $1,265,934 for the nine months ended June 30, 2026, compared with income in the prior-year periods. General and administrative expenses rose sharply while interest income from the Trust Account declined.
Cash and investments in the Trust Account were $8,261,479 and cash outside the trust was only $30,161, with a working capital deficit of $2,190,878. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
The company has entered into a Business Combination Agreement with GNQ Insilico Inc., supported by shareholder and sponsor agreements and a bridge financing structure of up to $2,000,000, including an initial $250,000 10% secured convertible note and accompanying warrants. Large stockholder redemptions removed approximately $106.1 million and $7.9 million from the Trust Account in two extension votes, leaving 759,139 public shares subject to redemption.
IB Acquisition Corp. reported a net loss of $639,866 for the quarter ended March 31, 2026, driven by higher general and administrative expenses of $748,177 and reduced interest income from its trust investments.
The SPAC’s trust account balance fell to $8.19M after significant redemptions, including about $7.9M at roughly $10.78 per share in March 2026. Common stock subject to possible redemption declined to 759,139 shares, while 4,249,090 non‑redeemable shares remained outstanding.
IB Acquisition entered into a Business Combination Agreement with GNQ Insilico Inc. and arranged up to $2.0M of 10% secured convertible bridge financing to support GNQ ahead of closing. Management disclosed only $4,634 of cash outside the trust and a working capital deficit of $1.55M, concluding these conditions raise substantial doubt about the company’s ability to continue as a going concern absent a successful merger.
IB Acquisition Corp. schedule amendment shows AQR Capital Management, LLC, AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC report 0 shares beneficially owned of common stock, representing 0% of the class as of 03/31/2026. The filing lists issuer address and identifies parent/subsidiary relationships; it is signed and dated 04/08/2026.